Schwicker, MA, David
Kontakt
DSCO – David Schwicker Consulting / ORPHA Strategy Consulting (Basel, Switzerland)
4
6167 Neustift im Stubaital
Fachgebiet / Branche
- Biotechnologie / Life Science
Spezialisierung
- Finanzierung / Finanzplanung
- Geschäftsmodellentwicklung
- Marketing
- Organisation
- Projektmanagement
Beschreibung
Founder of ORPHA Strategy Consulting, David is a sought-after expert for accelerating time to approval, launch and patient access for OMPs and ATMPs.
David’s experience includes rare oncology and haematology (ALL, AML, MM, CD30+ HL/NHL, CTCL, ALK+/EGFR+ NSCLC, breast cancer), metabolic and endocrine diseases (MPS, Graves’ disease, acromegaly), rare CNS disorders (CIDP, RTT, MG, narcolepsy, Friedrich’s ataxia), inherited retinal dystrophies (RA, LCA, USHERs), hepatic conditions (PSC), rare cardiopulmonary diseases (IPF, PAH, PH-ILD), dermatology (PN, EB, XLHED), and rare immunology (AMR, GvHD).
David is the author & coauthor of numerous peer-reviewed publications and speaker at international meetings (ISPOR, RAPS EU Congress, OMPs Development & Commercialisation, Expanded Access Summit).
He is an accomplished trainer in rare diseases, OMPs, ATMPs, as well as patient reported outcomes (PROs), and leads training courses as well as customized in-house training workshops.